Synthetic Lethality & Cancer Therapy

The genetic concept of synthetic lethality, in which the combination or synthesis of mutations in multiple genes results in cell death, provides a framework to design novel therapeutic approaches to cancer. Discover the latest research on synthetic lethality and cancer therapy here.

July 12, 2020

Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency

Proceedings of the National Academy of Sciences of the United States of America
Lena J McLaughlinFeyruz V Rassool
July 1, 2020
Open Access

The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation

Human Reproduction
Amy L WinshipKarla J Hutt
July 10, 2020

Reactivation of Epstein-Barr Virus By HIF-1α Requires p53

Journal of Virology
Richard J KrausJanet E Mertz
July 3, 2020
Open Access

Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer

Frontiers in Oncology
Xuan-Zhang HuangXin Zhou
July 1, 2020

Evolution of pathogenetic therapy of pulmonary arterial hypertension

Terapevticheskiĭ arkhiv
I E ChazovaN M Danilov
July 6, 2020
Review

Poly adenosine diphosphate-ribosylation and neurodegenerative diseases

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Yi Wang, Yunbi Lu
July 12, 2020

Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England

European Journal of Human Genetics : EJHG
Nicola FlaumD Gareth R Evans
July 9, 2020
Comment / Editorial

DNA Repair and Prostate Cancer: A Field Ripe for Harvest

European Urology
Alan H BryceJohann de Bono
July 1, 2020
Review
Open Access

Innovative Precision Gene-Editing Tools in Personalized Cancer Medicine

Advanced Science
Xiaofeng DaiKostya Ken Ostrikov
July 1, 2020
Review

Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy

Current Treatment Options in Oncology
Meera Ragavan, Millie Das
July 9, 2020
Open Access

Fluorescence-guided resection of tumors in mouse models of oral cancer

Scientific Reports
Paula Demétrio de Souza FrançaThomas Reiner
July 11, 2020

Efficacy and safety updates of poly ADP-ribose polymerase (PARP) inhibitor maintenance in ovarian cancer from ASCO 2020

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Ainhoa MadariagaStephanie Lheureux
June 26, 2020

Super-enhancer acquisition drives oncogene expression in triple negative breast cancer

PloS One
Ryan RaisnerKaren E Gascoigne

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2020 Meta ULC. All rights reserved
/feed-previews/synthetic-lethality-cancer-therapy/2f38aef1-ca52-4938-b478-877712653432